Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) today announced an update on the phase III, multicenter, double-blind STEP study of Ampion™ for osteoarthritis of the knee. The STEP study enrolled 538 patients, 269 patients received Ampion™ and 269 patients received saline vehicle control. There were two primary endpoints: 1. Efficacy in reducing pain, as measured by the WOMAC A pain subscore and 2. Safety of Ampion™ as measured by adverse events (AEs). The WOMAC C Function subscore was examined as a secondary endpoint. Changes in pain and function from baseline between Ampion™ and saline treatment groups were analyzed using a mixed model, adjusted for baseline score. Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) in last trading activity fell -5.78% to close at $4.24. Company weekly performance is -12.94% while its quarterly performance stands at -38.99%. Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) is -60.96% away from its 52 week high.
On August 20, 2014, Glu Mobile Inc. (NASDAQ:GLUU) completed its previously announced acquisition of Cie Games, Inc., a Delaware corporation (“Cie Games”), pursuant to an Agreement and Plan of Merger and Reorganization dated July 30, 2014 (the “Merger Agreement”) by and among Glu, Cie Games, Cie Digital Labs, LLC, a California limited liability company and the former holder of a majority of the outstanding capital stock of Cie Games, Cardinals Acquisition Merger Corporation, a Delaware corporation and a wholly owned subsidiary of Glu (“Sub I”), Cardinals Acquisition Merger LLC, a Delaware limited liability company and a wholly owned subsidiary of Glu (“Sub II”), and Shareholder Representative Services, LLC, as Stockholders’ Agent (the “Stockholders’ Agent”). On last trading day Glu Mobile, Inc. (NASDAQ:GLUU) advanced 0.80% to close at $5.03. Its volatility for the week is 4.21% while volatility for the month is 4.85%. GLUU’s sales growth for past 5 years was 3.30% and its EPS growth for past 5 years was 40.10%. Glu Mobile, Inc. (NASDAQ:GLUU) monthly performance is -7.20%.
D. Bryan Jordan, CEO of First Horizon National Corp. (NYSE:FHN), will present at the Barclays Global Financial Services Conference in New York City on Tuesday, Sept. 9, at 9:00 a.m. Eastern Time. On last trading day First Horizon National Corporation (NYSE:FHN) advanced 0.08% to close at $12.35. Its volatility for the week is 1.45% while volatility for the month is 1.43%. FHN’s sales growth for past 5 years was -14.50% and its EPS growth for past 5 years was 16.10%. First Horizon National Corporation (NYSE:FHN) monthly performance is 6.74%.
On JULY 25, Salisbury Bancorp, Inc (NASDAQ:SAL), the holding company for Salisbury Bank and Trust Company (the “Bank”), announced results for its second quarter ended June 30, 2014. Net income available to common shareholders was $926,000, or $0.54 per common share, for the quarter ended June 30, 2014 (second quarter 2014), versus $505,000, or $0.29 per common share, for the quarter ended March 31, 2014 (first quarter 2014), and $1,103,000, or $0.65 per common share, for the quarter ended June 30, 2013 (second quarter 2013). Salisbury Bancorp Inc. (NASDAQ:SAL) has 2.80% insider ownership while its institutional ownership stands at 10.50%. In last trading activity company’s stock closed at $29.50.
On AUG 15, Global Brass and Copper Holdings, Inc. (NYSE:BRSS) announced that its Board of Directors declared a quarterly cash dividend of $0.0375 per share on the Company’s common stock for the second quarter of 2014. The dividend will be paid on September 9, 2014 to stockholders of record on the close of business on August 26, 2014. On Wednesday shares of Global Brass and Copper Holdings, Inc. (NYSE:BRSS) closed at $14.86. Company’s sales growth for last 5 years was -2.60% and EPS growth for next 5 years is recorded as 10.00%.